A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle-specific genes

European Journal of Heart Failure

Volumn 17, Issue 5, 2015, Pages 484-493

  Harakalova, Magdalena ^a   Kummeling, Gijs ^a   Sammani, Arjan ^a   Linschoten, Marijke ^a   Baas, Annette F ^a   Van Der Smagt, Jasper ^a   Doevendans, Pieter A ^a   Van Tintelen, J Peter ^b   Dooijes, Dennis ^a   Mokry, Michal ^c   Asselbergs, Folkert W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Dilated cardiomyopathy; Extramuscular manifestations; Genetic testing; Tissue expressivity

Indexed keywords

MITOCHONDRIAL DNA; NUCLEAR PROTEIN;

ARRYTHMOGENIC CARDIOMYOPATHY; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CONGESTIVE CARDIOMYOPATHY; EMBASE; EXTRACHROMOSOMAL INHERITANCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDLINE; MYOPATHY; PERIPARTUM CARDIOMYOPATHY; PRIORITY JOURNAL; RNA SEQUENCE; SKELETAL MUSCLE; SYSTEMATIC REVIEW; TISSUE SPECIFICITY; DNA SEQUENCE; GENETICS; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE CELL; METABOLISM; PHENOTYPE; PHYSIOLOGY;

CARDIOMYOPATHY, DILATED; DNA, MITOCHONDRIAL; GENE EXPRESSION; GENETIC TESTING; HUMANS; MITOCHONDRIA, HEART; MUSCLE, SKELETAL; MYOCARDIUM; MYOCYTES, CARDIAC; NUCLEAR PROTEINS; PHENOTYPE; SEQUENCE ANALYSIS, DNA;

EID: 84928612092     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.255     Document Type: Article

References (24)

1. Hershberger RE, Hedges DJ, Morales A,. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 2013; 10: 531-547.
2. Michels VV, Driscoll DJ, Miller FA, Olson TM, Atkinson EJ, Olswold CL, Schaid DJ,. Progression of familial and non-familial dilated cardiomyopathy: long term follow up. Heart 2003; 89: 757-761.
3. Everly MJ,. Cardiac transplantation in the United States: an analysis of the UNOS registry. Clin Transpl 2008; 22: 35-43.
4. Aleksova A, Sabbadini G, Merlo M, Pinamonti B, Barbati G, Zecchin M, Bussani R, Silvestri F, Iorio AM, Stolfo D, Dal Ferro M, Dragos AM, Meringolo G, Pyxaras S, Lo Giudice F, Perkan A, di Lenarda A, Sinagra G,. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure-a subgroup analysis from the Trieste Cardiomyopathy Registry. J Cardiovasc Med (Hagerstown) 2009; 10: 699-705.
5. Murakami T, Hayashi YK, Noguchi S, Ogawa M, Nonaka I, Tanabe Y, Ogino M, Takada F, Eriguchi M, Kotooka N, Campbell KP, Osawa M, Nishino I,. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol 2006; 60: 597-602.
6. Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA, Heart Failure Society of A. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. J Card Fail 2009; 15: 83-97.
7. Roncarati R, Viviani Anselmi C, Krawitz P, Lattanzi G, Von Kodolitsch Y, Perrot A, Di Pasquale E, Papa L, Portararo P, Columbaro M, Forni A, Faggian G, Condorelli G, Robinson PN,. Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet 2013; 21: 1105-1111.
8. Posafalvi A, Herkert JC, Sinke RJ, van den Berg MP, Mogensen J, Jongbloed JD, van Tintelen JP,. Clinical utility gene card for: dilated cardiomyopathy (CMD). Eur J Hum Genet 2013; 21.
9. Wilde AA, Behr ER,. Genetic testing for inherited cardiac disease. Nat Rev Cardiol 2013; 10: 571-583.
10. Sikkema-Raddatz B, Johansson LF, de Boer EN, Almomani R, Boven LG, van den Berg MP, van Spaendonck-Zwarts KY, van Tintelen JP, Sijmons RH, Jongbloed JD, Sinke RJ,. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Hum Mutat 2013; 34: 1035-1042.
11. van der Zwaag PA, van Rijsingen IA, Asimaki A, Jongbloed JD, van Veldhuisen DJ, Wiesfeld AC, Cox MG, van Lochem LT, de Boer RA, Hofstra RM, Christiaans I, van Spaendonck-Zwarts KY, Lekanne dit Deprez RH, Judge DP, Calkins H, Suurmeijer AJ, Hauer RN, Saffitz JE, Wilde AA, van den Berg MP, van Tintelen JP,. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail 2012; 14: 1199-1207.
12. Lakdawala NK, Funke BH, Baxter S, Cirino AL, Roberts AE, Judge DP, Johnson N, Mendelsohn NJ, Morel C, Care M, Chung WK, Jones C, Psychogios A, Duffy E, Rehm HL, White E, Seidman JG, Seidman CE, Ho CY,. Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail 2012; 18: 296-303.
13. Herman DS, Lam L, Taylor MRG, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJR, Cook SA, Mestroni L, Seidman JG, Seidman CE,. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012; 366: 619-628.
14. Glockle N, Kohl S, Mohr J, Scheurenbrand T, Sprecher A, Weisschuh N, Bernd A, Rudolph G, Schubach M, Poloschek C, Zrenner E, Biskup S, Berger W, Wissinger B, Neidhardt J,. Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies. Eur J Hum Genet 2014; 22: 99-104.
15. Mestroni L, Taylor MR,. Genetics and genetic testing of dilated cardiomyopathy: a new perspective. Discov Med 2013; 15: 43-49.
16. Kesari A, Neel R, Wagoner L, Harmon B, Spurney C, Hoffman EP,. Somatic mosaicism for Duchenne dystrophy: evidence for genetic normalization mitigating muscle symptoms. Am J Med Genet 2009; 149A: 1499-1503.
17. Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, Tsikas D, Jordan J, Lichtinghagen R, Von Kaisenberg CS, Struman I, Bovy N, Sliwa K, Bauersachs J, Hilfiker-Kleiner D,. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 2013; 108: 366.
18. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, Dooijes D, van den Berg MP,. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010; 121: 2169-2175.
19. Hershberger RE, Siegfried JD,. Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 2011; 57: 1641-1649.
20. Hershberger RE, Morales A, Siegfried JD,. Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med 2010; 12: 655-667.
21. Castle JC, Armour CD, Lower M, Haynor D, Biery M, Bouzek H, Chen R, Jackson S, Johnson JM, Rohl CA, Raymond CK,. Digital genome-wide ncRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification. PLoS One 2010; 5: e11779.
22. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, Bowser M, Harrison B, Aaron D, Mahanta LM, Lakdawala NK, McDermott G, White ET, Rehm HL, Lebo M, Funke BH,. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med 2014; 16: 601-608.
23. MacArthur DG, Manolio TA, Dimmock DP, Rehm HL, Shendure J, Abecasis GR, Adams DR, Altman RB, Antonarakis SE, Ashley EA, Barrett JC, Biesecker LG, Conrad DF, Cooper GM, Cox NJ, Daly MJ, Gerstein MB, Goldstein DB, Hirschhorn JN, Leal SM, Pennacchio LA, Stamatoyannopoulos JA, Sunyaev SR, Valle D, Voight BF, Winckler W, Gunter C,. Guidelines for investigating causality of sequence variants in human disease. Nature 2014; 508: 469-476.
24. Andreasen C, Nielsen JB, Refsgaard L, Holst AG, Christensen AH, Andreasen L, Sajadieh A, Haunso S, Svendsen JH, Olesen MS,. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet 2013; 21: 918-928.